Elevance Health
ELV
772 hedge funds and large institutions have $32.9B invested in Elevance Health in 2016 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 276 increasing their positions, 307 reducing their positions, and 56 closing their positions.
23% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 56
1% more funds holding
Funds holding: 766 → 772 (+6)
0.22% less ownership
Funds ownership: 90.89% → 90.67% (-0.22%)
0% less capital invested
Capital invested by funds: $33B → $32.9B (-$110M)
10% less repeat investments, than reductions
Existing positions increased: 276 | Existing positions reduced: 307
22% less call options, than puts
Call options by funds: $91.7M | Put options by funds: $118M
25% less funds holding in top 10
Funds holding in top 10: 28 → 21 (-7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$102M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$97.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$80.1M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$69.3M |
| 5 |
JP Morgan Chase
New York
|
+$67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$246M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$165M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$137M |
| 4 |
GCM
Glenview Capital Management
New York
|
-$88.1M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$69.1M |
ELV Hedge Fund Activity: Q1 2016 in Review
772 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q1 2016, worth a combined $32.9B — down 0.33% from $33B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new ELV positions and 56 closed out — a net gain of 13 holders — while 276 added to existing stakes and 307 trimmed.
The largest buyer was Waddell & Reed Financial, adding an estimated $102M. The largest seller was Viking Global Investors, cutting an estimated $246M.
- 772 institutional investors held Elevance Health (ELV) as of Q1 2016, up from 766 in Q4 2015.
- Funds reported $32.9B of Elevance Health stock for Q1 2016, down 0.33% quarter-over-quarter.
- 69 funds opened new Elevance Health positions in Q1 2016 and 56 closed out, a net change of +13 holders.
- The largest Elevance Health buyer in Q1 2016 was Waddell & Reed Financial, an estimated $102M added.
- The largest Elevance Health seller in Q1 2016 was Viking Global Investors, an estimated $246M sold.
Based on aggregated 13F filings for Q1 2016.